Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021417
Company: WYETH PHARMS INC
Company: WYETH PHARMS INC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
PREMARIN | ESTROGENS, CONJUGATED | 0.3MG | TABLET; ORAL | Prescription | None | No | No |
PREMARIN | ESTROGENS, CONJUGATED | 0.45MG | TABLET; ORAL | Prescription | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
07/16/2003 | ORIG-1 | Approval | Type 6 - New Indication (no longer used) | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-417_Premarin_prntlbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21417ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-417_Premarin.cfm |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
07/16/2003 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-417_Premarin_prntlbl.pdf |